Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIPEC as NACT and Postoperative Chemotherapy in Advanced Ovarian Cancer
NCT03180177Phase 3Unknown
- Start
- Mar 2018
- Primary completion
- Jul 2021
- Modality
- Nanoparticles, Cytokines & Interferons, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Cisplatin micelle injection (HA132), Paclitaxel Micelles for Injection in epithelial ovarian cancer (EOC), fallopian tube cancer (PFTC), primary peritoneal carcinoma (PPC). Status: unknown.
02
Drugs
Cisplatin micelle injection (HA132)Paclitaxel Micelles for Injection
03
Conditions
epithelial ovarian cancer (EOC)fallopian tube cancer (PFTC)primary peritoneal carcinoma (PPC)
Beyond the preview
Go deeper on NCT03180177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03180177.